These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8494718)

  • 21. Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection.
    Smythe JA; Symonds G
    Inflamm Res; 1995 Jan; 44(1):11-5. PubMed ID: 7664023
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of antisense vectors and oligodeoxynucleotides in neuro-oncology.
    Engelhard HH; Egli M; Rozental JM
    Pediatr Neurosurg; 1998 Jun; 28(6):279-85. PubMed ID: 9782204
    [No Abstract]   [Full Text] [Related]  

  • 23. Antisense therapeutics.
    Persidis A
    Nat Biotechnol; 1999 Apr; 17(4):403-4. PubMed ID: 10207893
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene regulation by antisense RNA and DNA.
    Case CC; Dhundale AR
    Antisense Res Dev; 1991; 1(2):207-17. PubMed ID: 1841663
    [No Abstract]   [Full Text] [Related]  

  • 25. Hammerhead ribozymes: biochemical and chemical considerations.
    Goodchild J
    Curr Opin Mol Ther; 2000 Jun; 2(3):272-81. PubMed ID: 11249621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?
    Akhtar S; Rossi JJ
    J Antimicrob Chemother; 1996 Aug; 38(2):159-65. PubMed ID: 8877530
    [No Abstract]   [Full Text] [Related]  

  • 27. Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
    Zaia JA; Chatterjee S; Wong KK; Elkins D; Taylor NR; Rossi JJ
    Ann N Y Acad Sci; 1992 Oct; 660():95-106. PubMed ID: 1340161
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants.
    von Weizsäcker F; Wieland S; Köck J; Offensperger WB; Offensperger S; Moradpour D; Blum HE
    Hepatology; 1997 Aug; 26(2):251-5. PubMed ID: 9252130
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of antisense therapeutics. Implications for cancer gene therapy.
    Milligan JF; Jones RJ; Froehler BC; Matteucci MD
    Ann N Y Acad Sci; 1994 May; 716():228-41. PubMed ID: 8024196
    [No Abstract]   [Full Text] [Related]  

  • 30. Message therapy: gene therapy that targets mRNA sequence and stability.
    Kozarsky KF; Couture LA
    Am J Hum Genet; 1997 Oct; 61(4):790-4. PubMed ID: 9382086
    [No Abstract]   [Full Text] [Related]  

  • 31. Antisense oligonucleotides.
    Herdewijn P
    Verh K Acad Geneeskd Belg; 1996; 58(4):359-81. PubMed ID: 8956554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antisense strategies come of age].
    Yokoyama K
    Tanpakushitsu Kakusan Koso; 1993 Mar; 38(4):753-65. PubMed ID: 8475331
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-oncogene and tumor suppressor gene therapy--examples from a lung cancer animal model.
    Zhang WW; Roth JA
    In Vivo; 1994; 8(5):755-69. PubMed ID: 7727723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An indexed bibliography of antisense literature, 1991.
    Antisense Res Dev; 1992; 2(1):63-107. PubMed ID: 1422087
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic implications of antisense oligonucleotides.
    Lattuada D; Mazzei M; Meazza R; Nicolin A
    Int J Clin Lab Res; 1992; 21(4):296-9. PubMed ID: 1591383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
    Nash KL; Alexander GJ; Lever AM
    J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense applications for biological control.
    Pan WH; Clawson GA
    J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long march of antisense.
    Jones D
    Nat Rev Drug Discov; 2011 Jun; 10(6):401-2. PubMed ID: 21629279
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic oligonucleotides.
    Goodchild J
    Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 10th International Conference on gene therapy of cancer: 13 - 15 December 2001, San Diego, CA, USA.
    Chen Y
    Expert Opin Biol Ther; 2002 Apr; 2(4):443-5. PubMed ID: 11955281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.